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doi:10.1Background: A combined open surgical and endovascular approach to managing aneurysms of the distal aortic
arch (hybrid arch repair) is evolving as a viable treatment option. Our aim is to describe a treatment strategy in
high-risk patients and report the technical and clinical success of the hybrid approach to aneurysms involving the
distal aortic arch.
Methods: From July 2005 until December 2009, 27 consecutive patients with aneurysms of the distal aortic arch
were treated via a hybrid arch repair. Of this group, 23 patients underwent aortic arch debranching and revascu-
larization before endovascular stent deployment in the ascending aorta (type I). Four patients required ascending
aortic and transverse arch replacement before stent graft deployment (type II).
Results: A stent graft was successfully deployed in 100% of patients after aortic arch vessel debranching via
median sternotomy. The mean age of the patients was 71  7.5 years. The average cardiopulmonary bypass
time was 199  84 minutes with an average crossclamp time of 57  53 minutes. Deep hypothermic circulatory
arrest was required in 4 patients (all type II). The average length of stay was 17.2  14 days. The complications
included stroke in 3 (11%) patients, permanent paralysis in 2 (7%), and perioperative death in 3 (11%) patients.
Conclusions: Early results of type I and II hybrid arch repair, in this cohort of patients with mutiple comorbid risk
factors, are acceptable and even encouraging. This evolving approach to aneurysms involving the aortic arch may
extend the indications for use of endovascular prostheses in the treatment of patients with complex aortic arch
disease. (J Thorac Cardiovasc Surg 2010;140:S77-80)Aortic arch replacement for extensive and complex arch dis-
ease is technically challenging. Open total arch and total
arch plus descending aortic procedures can be accomplished
electively with complex circulatory management and ad-
junct cerebral protection. However, these procedures, espe-
cially when staged, have been associated with significant
and sometimes prohibitive morbidity and mortality for those
patients with multiple comorbidities.1-6
Thoracic endovascular repair has emerged as a treatment
alternative for uncomplicated aortic disease of the descending
thoracic aorta with acceptable midterm morbidity and
mortality, and recently endovascular repair has been
advocated for complicated aortic disease including type A
dissections.1,2,7-10 The hybrid arch repair combines an open
procedure to secure a proximal landing zone with
concomitant antegrade endovascular stent graft placement in
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The Journal of Thoracic and Carfeasibility of these procedures, with acceptable mortality and
neurologic outcomes.1,7,9,10
Appropriate selection of patients is essential when consid-
ering an endovascular versus open aortic approach for com-
plex aortic arch disease. We prefer the hybrid approach
when multiple comorbidities make a traditional open repair
high risk. This study evaluates the outcomes of a contempo-
rary series of procedures from one institution for extensive
aortic arch disease: open total arch, total arch plus descend-
ing aorta, and hybrid arch repairs (types I and II).
METHODS
Patient Characteristics
From 2005 to 2009, we performed 81 hybrid endovascular procedures via
sternotomy. Forty-five were emergency DeBakey I dissections with a distal
stented elephant trunk, and 9 patients received concomitant ascending and
extended arch replacement, with staged stent graft placement (either during
the same hospital stay or on a second admission). Twenty-seven were classic
electiveopenbrachiocephalic debranchingprocedureswith concomitant endo-
vascular stent graft placement (hybrid arch). Hybrid arch procedures included
23 patients undergoing brachiocephalic debranching with endovascular stent
graft placement alone (type I hybrid) and 4 patients with concomitant ascend-
ing arch replacement (type II hybrid) to establish a suitable proximal landing
zone. The type III hybrid includes the previously mentioned 9 patients
undergoing concomitant ascendingand extended arch replacementwith staged
stent graft placement: these were not included in this analysis. Mean age was
71.2  7.5 years. The mean maximum size of atherosclerotic aneurysm was
7.4 1.7 cm. Preoperative patient characteristics are summarized in Table 1.
Surgical Technique
For arch aneurysms treatable with a type I hybrid reconstruction (the
classic debranching procedure), the procedure was performed withdiovascular Surgery c Volume 140, Number 6S S77
TABLE 1. Preoperative characteristics
Preoperative characteristics Hybrid Type 1 Type 2
N 27 23 4
Age (y) 71.2  7.5 70.5  8.7 75.0  4.3
Gender (N male) 18 67% 0 0% 0 0%
Prior CVA 12 44% 10 43% 2 50%
Prior MI 5 19% 5 22% 0 0%
CRI 5 19% 0 0% 0 0%
Smoker 22 81% 19 83% 3 75%
Type of disease
Aneurysm 26 96% 22 96% 4 100%
Fusiform 5 19% 3 13% 2 50%
Saccular 21 78% 19 83% 2 50%
Maximum diameter (mean, cm) 7.4  1.7 7.3  1.7 8.6  0.8
Pseudoaneurysm (posttraumatic transection) 1 4% 1 4%
CVA, Cerebrovascular accident; MI, myocardial infarction; CRI, chronic renal insufficiency.
Aortic Symposium 2010 Bavaria et ala 4-branched Dacron graft anastomosed in an end-to-side fashion along the
greater curve of the ascending aorta, just distal to the sinotubular junction, to
allow deployment of the stent graft in the ascending aorta without compro-
mise of the proximal inflow anastomosis. When performed off bypass (type
IA, n¼ 7), a side-biting clamp was used on the ascending aorta. If a limited
amount of aorta existed between the sinotubular junction and the ascending
aorta, full cardiopulmonary bypass with aortic crossclamping and cardiac
arrest using standard cardioplegia was required (type IB, n ¼ 15).
For patients undergoing a type II repair, deep hypothermic circulatory ar-
rest was used. A segment of aorta just distal to the sinotubular junction was
identified for the proximal anastomosis, and normalization of the sinotubu-
lar junction was performed with the 4-branched aortic graft. After profound
hypothermia and a flat electroencephalogram had been achieved, retrograde
cerebral perfusion was initiated, and the aortic arch was opened. Retrograde
cerebral perfusion was usually performed for a brief period before selective
antegrade cerebral perfusion while the proximal aortic arch was prepared for
the hybrid procedure. After complete dissection of the brachiocephalic ves-
sels from the aortic arch, the distal aortic arch anastomosis was completed.
For all hybrid arch procedures, the distal end-to-end anastomosis of the
branched grafts to the arch vessels was sequentially performed for the left
subclavian, left common carotid, and innominate arteries. The proximal
takeoff of each arch vessel was detached with a stapling device. Deairing
maneuvers were performed for each anastomosis before release of the distal
clamp. The Gore TAG thoracic endoprosthesis (W.L. Gore & Associates,
Inc, Flagstaff, Ariz) was used in 24 of 27 patients. One Medtronic Talent
device (Medtronic, Inc, Minneapolis, Minn) and 2 Cook TX2 devices
(Cook Medical, Bloomington, Ind) were used in the remaining patients.
The stent-graft devices were deployed under fluoroscopy, and completion
angiography was performed in all cases. Deployment of the stent graft
was successful in 100% of cases. The average endovascular pavement
length for type I was 26.8  8.5 cm; it was 31.3  21.4 cm for type II.TABLE 2. Operative times
Intraoperative Hybrid
N 27
Off pump 7 26%
CPB time 199.5  84.0
Clamp time 57.9  53.0
Arrest? 4 15%
Arrest time (total, min) 64.5  14.5
RCP time (min) 13.5  6.0
ACP time (min) 51.0  10.9
CPB, Cardiopulmonary bypass; RCP, retrograde cerebral perfusion; ACP, antegrade cereb
S78 The Journal of Thoracic and Cardiovascular SurgRESULTS
Ninety-six percent of patients undergoing the classic hy-
brid procedure had atherosclerotic disease. Saccular athero-
sclerotic disease was prevalent in patients undergoing hybrid
procedures (78%) (Table 1). Intraoperative variables are de-
scribed in Table 2.
Transient reversible spinal cord ischemia occurred in 3
(11%) hybrid arch procedures. Two (7%) patients undergo-
ing the hybrid arch procedure had new postoperative para-
plegia develop, and both died before hospital discharge.
Permanent cerebral neurologic deficits, embolic in origin,
occurred in 3 (11%, 1 death) patients in the hybrid arch
group. Other outcomes are described in Table 3.
Thirty-day mortality was 11%. When stratified by age,
there are no significant differences for in-hospital mortality
between groups: patients less than 75 years (1 death, 12
patients, 6%) and patients more than 75 years (2 deaths,
15 patients, 16%) did not have significantly different rates
of death. Age was not a factor for neurologic deficit or post-
operative renal failure. No endoleaks occurred in any patient
(0%). Mean length of follow up was 20.5  17.4 months.DISCUSSION
Although operative approaches for complex aortic
diseases have evolved over the past 25 years, an optimalType 1 Type 2
23 4
7 30%
179.9  75.2 278.0  47.5
42.3  29.2 120.3  75.7
0 0% 4.0 100%
64.5  14.5
13.5  6.0
51.0  10.9
ral perfusion.
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TABLE 3. Postoperative outcomes
Outcomes Hybrid Type 1 Type 2
N 27 23 4
Thirty-day mortality 3 11% 3 13% 0
Stroke 3 11% 3 13% 0
Permanent paraplegia 2 7% 2 9%
Transient neurologic deficit 3 11% 2 9% 1 25%
Renal failure 2 7% 2 9% 0
Renal failure requiring new hemodialysis 1 4% 1 4% 0
Reop for bleeding 0 0%
Atrial fibrillation 12 44% 10 43% 2 50%
Mean hospital stay (d) 17.2  14.0 16.3  14.0 22.0  9.6
Bavaria et al Aortic Symposium 2010surgical technique has not been definitively established. Al-
though the results of open total arch repair have improved,
the morbidity and mortality associated with conventional re-
pair using cardiopulmonary bypass and deep hypothermic
circulatory arrest are not insignificant. For complicated aortic
arch disease in patients with multiple prohibitive comorbid-FIGURE 1. Type I aortic disease. For type I saccular arch aneurysm, the classic
procedure involves the end-to-side anastomoses of a 4-branched graft to the asc
ascending aorta (IA). If a limited amount of aorta exists between the sinotubular
clamp is required (IB). Type II aortic arch disease. This aortic disease has no ade
ployment of the endovascular graft. However, this pathologic condition requires
arch disease. For type III aortic arch disease, or mega-aorta, there is no adequa
suitable distal native aorta extends to just proximal to the celiac artery. Mega-ao
graft. The remaining mega-aorta is addressed by thoracic endovascular aortic repa
the open debranching procedure and completion of aneurysmal exclusion with f
The Journal of Thoracic and Carities, the hybrid procedure can be performed with acceptable
morbidity and mortality.1,7,9,10 This complex aortic disease
requires precise management and often modification of
landing zones for endovascular placement.1,7,10
In our series, for patients with type I saccular arch disease
(n ¼ 17) with suitable native proximal and distal landingdebranching procedure can be performed to bypass the cerebral vessels. This
ending aorta. This can be done off bypass with a side-biting clamp on the
junction and the ascending aorta, full cardiopulmonary bypass with cross-
quate suitable native proximal aorta but has a distal aorta for antegrade de-
construction of a landing zone 0 site with a 4-branched graft. Type III aortic
te suitable native proximal ascending or descending aorta. The inadequate
rta also requires reconstruction of a landing zone 0 site with a 4-branched
ir during the same hospitalization (IIIA). In some cases, an interval between
urther endovascular stent grafting is required (IIIB).
diovascular Surgery c Volume 140, Number 6S S79
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graft and antegrade deployment of the endovascular stent
into the native ascending aorta was performed either off
(type IA) or on (type IB) cardiopulmonary bypass. For
type II arch disease (n ¼ 2) (with an unsuitable proximal
landing zone but suitable distal landing zones), ascending
aortic reconstruction of landing zone 0 with the 4-branched
graft and endovascular stent deployment into the Dacron
ascending aorta was performed. The types of hybrid proce-
dures are illustrated in Figure 1.
Analysis of the 27 patients with a classic hybrid arch
revealed that 96% had atherosclerotic aneurysms. No endo-
leaks occurred in our series. The overall mortality was 11%
in this cohort of patients. This is consistent with mortality
seen in other hybrid series (0%–15%).1,7,9-11 In our
classic hybrid arch group, the incidence of permanent
cerebral neurologic deficit was 11%. Paraplegia occurred
in 2 (7%) patients and is consistent with other hybrid
series, which report a 0% to 10% incidence of
paraplegia.1,7,9-11 Both of these patients were treated early
in our series: one had extensive aneurysmal disease
including abdominal aortic aneurysm requiring distal stent
deployment to the celiac artery. Extensive endovascular
stent placement in conjunction with abdominal aortic
aneurysm has been associated with spinal cord injury.11
Atherosclerotic disease is a predictor of perioperative
stroke.4,12 Delineation of atherosclerotic aneurysms in
patients undergoing hybrid procedures revealed that 78%
(21/27) were saccular arch aneurysms. Previously, these
patients have been considered to be at prohibitively high
risk for conventional open arch repair owing the
associated high stroke risk. Recent series of total arch
repair for large atherosclerotic arch aneurysms still report
in-hospital mortality ranging from 6.3% to 20% and an
incidence of stroke up to 12%.1,3,4,6,12 Atherosclerotic
burden was defined as high grade or mobile atheroma in
52% (14/27) of patients. In our series, the overall
incidence of permanent cerebral neurologic deficit was 8%.
An algorithmic approach to patient selection and opera-
tive approach—whether hybrid or open arch repair—must
be based on presenting comorbidities such as a significant
smoking history, moderate to severe chronic obstructive
pulmonary disease, saccular aneurysm with significant
atherosclerotic burden, and high-grade or mobile atheroma.
As older populations with additional comorbidities present
with aortic pathologic conditions, innovative methods of
treatment must be developed to achieve acceptable
outcomes.
Selection criteria for hybrid procedures are based on age,
aortic disease, and comorbidities. For this cohort, they in-
cluded aneurysms shown on computed tomographic angiog-
raphy as either saccular or with significant atherosclerotic
burden and transesophageal echocardiographic/computed
tomographic evidence of high-grade or mobile atheroma.S80 The Journal of Thoracic and Cardiovascular SurgThe selection criteria also included many patients with sig-
nificant smoking history and moderate to severe chronic ob-
structive pulmonary disease who would not likely tolerate
a left thoracotomy or a thorocosternotomy; those with
chronic renal failure and patients with other comorbidities
who would not tolerate an open staged procedure; as well
as patients with significant preoperative neurologic compro-
mise (previous cerebrovascular accident or paraplegia).
Exclusion criteria for hybrid arch reconstruction include
younger patients, patients with vascular disease such as
Marfan syndrome, and those with infection.
CONCLUSIONS
The hybrid arch repair for aortic arch aneurysms
continues to evolve with improvement in perioperative mor-
bidity and mortality. These data suggest that hybrid arch re-
pairs are safe and effective for high-risk patients. The results
of hybrid arch repairs must be measured against the results of
proven conventional open surgical techniques. The limited
data are encouraging although the enthusiastic application
of this new technology must be tempered with caution.
Larger series of hybrid arch repairs with longer follow-up
must be examined before these techniques can be extended
to patients with lower risk.References
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